Recap: Lineage Cell Therapeutics Q2 Earnings



Lineage Cell Therapeutics LCTX reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.


Lineage Cell Therapeutics reported in-line EPS of $-0.04 versus an estimate of $-0.04.

Revenue was up $4.04 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 5.08% drop in the share price the next day.


To track all earnings releases for Lineage Cell Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!